SIBN — SI-BONE, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1459839 ·
Last close
$18.59
Market Cap
$833.18M
52W High
$21.89
52W Low
$11.48
ADV30
568,323
Next earnings
2026-11-09
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 56,010,000 | 44,548,000 | -4,806,000 | -4,088,000 | 248,758,000 | 33,128,000 | 66,411,000 |
| Mar 2026 | 52,588,000 | 41,944,000 | -5,093,000 | -4,334,000 | 242,718,000 | 33,535,000 | 63,776,000 |
| Dec 2025 | 56,349,000 | 44,531,000 | -2,463,000 | -1,644,000 | 238,555,000 | 42,240,000 | 61,023,000 |
| Sep 2025 | 48,656,000 | 38,846,000 | -5,383,000 | -4,566,000 | 234,273,000 | 26,487,000 | 62,147,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,478,000
Investing CF
$-5,969,000
Financing CF
$2,702,000
CapEx
$-6,865,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.34
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-458,680,000
Inventory
$38,389,000
Receivables
$31,180,000
ST Investments
$112,813,000
EBIT TTM
$-12,142,000
Pretax Income TTM
$-14,632,000
Interest Exp TTM
$2,490,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$213,603,008
EBITDA
$-11,325,000
Free Cash Flow
$-861,875
Enterprise Value
$720,619,392
Total Cash
$145,940,992
Total Debt
$42,795,000
Shares Out
44,818,575
Trailing EPS
$-0.33
Book Value
$4.08
ROE
-8.3%
ROA
-4.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 200,925,000 | -22,330,000 | -18,904,000 | 238,555,000 | 61,023,000 | 177,532,000 | -675,000 |
| Dec 2024 | 167,178,000 | -35,248,000 | -30,913,000 | 230,437,000 | 63,473,000 | 166,964,000 | -12,425,000 |
| Dec 2023 | 138,886,000 | -46,931,000 | -43,336,000 | 230,425,000 | 61,050,000 | 169,375,000 | -18,713,000 |
| Dec 2022 | 106,409,000 | -59,609,000 | -61,256,000 | 157,552,000 | 59,250,000 | 98,302,000 | -41,655,000 |
TTM Snapshot
Revenues TTM
$148,076,000
NetIncome TTM
$-37,297,000
OpCashFlow TTM
$0
Assets (Latest)
$238,555,000
Forward EPS
$-0.33
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $17.50 · spot: $18.59 · call volume: 18 · put volume: 1,920
Expected Move to 2026-10-16:
±$3.27
(17.59%) —
implied range
$15.32 –
$21.86
· ATM straddle on $17.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INMD | InMode Ltd. | $820.58M | $14.26 | — |
| SGP | SpyGlass Pharma, Inc. | $905.44M | $27.07 | — |
| CBLL | Ceribell, Inc. | $909.18M | $23.69 | — |
| AVR | Anteris Technologies Global Corp. | $749.46M | $7.69 | — |
| BVS | Bioventus Inc. | $943.29M | $13.81 | — |
News headlines (Yahoo Finance, 1h cache)
Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?
2026-08-25 16:00 · Yahoo
SI-BONE (SIBN) Q2 2026 Earnings Call Transcript
2026-08-11 01:29 · Yahoo
Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?
2026-08-06 13:55 · Yahoo
SI-BONE Inc (SIBN) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...
2026-08-04 05:07 · Yahoo
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates
2026-08-03 22:45 · Yahoo
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
2026-08-03 20:09 · Yahoo
SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026
2026-07-20 20:09 · Yahoo
Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now
2026-06-03 13:55 · Yahoo
Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know
2026-06-01 13:55 · Yahoo
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%
2026-05-15 13:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.